Annual report pursuant to Section 13 and 15(d)

Consolidated Balance Sheets

v3.24.1
Consolidated Balance Sheets - USD ($)
Dec. 31, 2023
Dec. 31, 2022
Current Assets:    
Cash $ 1,975,799 $ 6,970,110
Prepaid expenses and other current assets 1,664,107 1,958,280
Total Current Assets 3,639,906 8,928,390
Intangible assets, net 1,619,570 1,658,858
In-process research and development 9,063,000
Total Assets 5,259,476 19,650,248
Current Liabilities:    
Accounts payable 1,892,611 1,801,210
Accrued expenses 1,869,814 2,284,516
Loans payable - current portion 1,034,124 1,308,516
Derivative liabilities 58 75,381
Total Current Liabilities 5,062,616 5,657,782
Loans payable - noncurrent portion 19,936 31,189
Deferred tax liability 304,657 2,617,359
Total Liabilities 5,387,209 8,306,330
Commitments and contingencies (Note 9)
Stockholders’ (Deficit) Equity:    
Preferred stock value
Common stock, $0.0001 par value; 100,000,000 shares authorized; 534,719 and 197,209 shares issued and outstanding at December 31, 2023 and 2022, respectively 54 20
Additional paid-in capital 130,117,209 121,637,966
Accumulated other comprehensive income (2,901,339) (2,885,523)
Accumulated deficit (127,343,657) (107,408,545)
Total Stockholders’ (Deficit) Equity (127,733) 11,343,918
Total Liabilities and Stockholders’ Equity 5,259,476 19,650,248
Class C Preferred Stock    
Stockholders’ (Deficit) Equity:    
Preferred stock value
Class K Preferred Stock    
Stockholders’ (Deficit) Equity:    
Preferred stock value
Related Party    
Current Liabilities:    
Accounts payable – related parties 266,009
Accrued expenses - related parties $ 188,159